Safety Study of Single Administration Intravenous Treatment for Influenza

NCT01375985 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

8

Enrollment

INDUSTRY

Sponsor class

Stopped The study was halted after enrollment of the first cohort because of lack of funding

Conditions

Influenza

Interventions

DRUG: AVI-7100
DRUG: Placebo

Sponsor

Sarepta Therapeutics, Inc.